Infection Prevention Differs Between Small, Large Hospitals
THURSDAY, Aug. 9, 2018 -- Small and large hospitals differ in infection preventionist (IP) staffing and infection prevention and control (IPC) resources, according to a study published in the Au
FDA Approves Arakoda
FDA Approves Arakoda (tafenoquine) for the Prevention of Malaria
WASHINGTON, Aug. 9, 2018 /PRNewswire/ -- 60 Degrees Pharmaceuticals (60P) announced today the U.S. Food and Drug Administration (FDA) approval of Arakoda (tafenoquine)
FDA Approves Poteligeo
FDA Approves Poteligeo (mogamulizumab-kpkc) for Mycosis Fungoides and Sézary Syndrome
August 8, 2018 -- The U.S. Food and Drug Administration today approved Poteligeo (mogamulizumab-kpkc) injection for intravenous use for the tr
Experimental Drug Slows Mental Decline in Alzheimers Patients
FRIDAY, July 27, 2018 -- An experimental drug appears to slow mental decline by as much as 30 percent in Alzheimers disease patients, according to research presented at the annual Alzheimers A
Americans Say Editing Babys Genes OK, Up to a Point: Poll
FRIDAY, July 27, 2018 -- Gene editing is no longer just fodder for sci-fi movies. Most Americans believe its OK to tweak a babys DNA under certain circumstances, a new poll finds.
The Pew Resea
FDA Approves Orilissa
FDA Approves Orilissa (elagolix) for the Management of Moderate to Severe Pain Associated with Endometriosis
NORTH CHICAGO, Ill., July 24, 2018 /PRNewswire/ -- AbbVie (NYSE: ABBV), a research-based global biopharmaceutical company,